Image
larger text    
   


 
 
  • About APIC
  • Member Services
  • Education & Certification
  • Research Foundation
  • Guidelines & Standards
  • Public Policy
  • Resources/Information Services
  • Emergency Preparedness
   
 
 


West Nile Virus

Table of Contents


General Information

What Is It?

West Nile virus (WNV) has emerged in recent years in temperate regions of Europe, Africa, Israel, and North America, presenting a threat to public health, equine health, and since 1999, the health of bird populations. The most serious manifestation of infection is fatal encephalitis (inflammation of the brain) in humans and horses, as well as mortality in certain domestic and wild birds.

Prior to August 1999, WNV had never been reported in the Western Hemisphere. In 1999, 62 cases of severe disease, including seven deaths, occurred in the New York City area. In 2000, 21 human cases occurred in the New York City area, northern New Jersey, and southwest Connecticut. In 2003, most states in the U.S. had recovered WNV in humans, horses, and birds.

What Are the Symptoms of WNV?

Most infections are mild, and symptoms include fever, headache, and body aches, often with skin rash and swollen lymph nodes. Following transmission by an infected mosquito, WNV multiplies in the person’s blood system and crosses the blood-brain barrier to reach the brain. The virus interferes with normal central nervous system functioning and causes inflammation of brain tissue. More severe infection may be marked by headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, paralysis, and rarely, death.

How Does West NileVirus Spread?

People get WNV from the bite of a mosquito that is infected with WNV. Mosquitoes become infected when they feed on infected birds, which may circulate the virus in their blood for a few days. After an incubation period of 10 days to 2 weeks, infected mosquitoes can transmit WNV virus to humans and animals while biting to take blood.

How Is WNV Infection Treated?

There is no specific treatment for WNV. In more severe cases, intensive supportive therapy is indicated, i.e., hospitalization, intravenous (IV) fluids, airway management, respiratory support (ventilator) if needed, prevention of secondary infections (pneumonia, urinary tract, etc.), and good nursing care. Currently there is no vaccine for WNV.

What Should I Do if I Think I Have WNV?

Milder WNV illness improves on its own, and people do not necessarily need to seek medical attention for this infection though they may choose to do so. If you develop symptoms of severe WNV illness, such as unusually severe headaches or confusion, seek medical attention immediately. Severe WNV illness usually requires hospitalization. Pregnant women and nursing mothers are encouraged to talk to their doctor if they develop symptoms that could be WNV.

What Is the Risk of Getting Sick from WNV?

  • People over 50 at higher risk to get sick. People over the age of 50 are more likely to develop serious symptoms of WNV if they do get sick and should take special care to avoid mosquito bites.
  • Being outside means you're at risk. The more time you're outdoors, the more time you could be bitten by an infected mosquito. Pay attention to avoiding mosquito bites if you spend a lot of time outside, either working or playing.
  • Risk through medical procedures is very low. All donated blood is checked for WNV before being used. The risk of getting WNV through blood transfusions and organ transplants is very small, and should not prevent people who need surgery from having it. If you have concerns, talk to your doctor.
  • Pregnancy and nursing do not increase risk of becoming infected withWNV. The risk thatWNV may present to a fetus or an infant infected through breastmilk is still being evaluated. Talk with your care provider is you have concerns.

What Can I Do to Prevent WNV?
The easiest and best way to avoid WNV is to prevent mosquito bites.

  • When you are outdoors, use insect repellents containing DEET (N, N-diethyl-meta-toluamide). Follow the directions on the package.
  • Many mosquitoes are most active at dusk and dawn. Be sure to use insect repellent and wear long sleeves and pants at these times or consider staying indoors during these hours. Light-colored clothing can help you see mosquitoes that land on you.
  • Make sure you have good screens on your windows and doors to keep mosquitoes out.
  • Get rid of mosquito breeding sites by emptying standing water from flower pots, buckets and barrels. Change the water in pet dishes and replace the water in bird baths weekly. Drill holes in tire swings so water drains out. Keep children's wading pools empty and on their sides when they aren't being used.

An educational pamphlet on the West Nile Virus, along with other educational pamphlets, is available for free download  here.

Visit the CDC Website to learn how to “Fight the Bite”and Protect Yourself Against West Nile Virus.


Additional Resources

CLINICIAN/CONSUMER

EID Cover Journal (Vol 7 No 4 )
Neither signed nor dated, The Mosquito Net was retained by Sargent until the end of his life and has long been ranked among his best "private" works-small paintings done for his own delectation rather than for a patron. The woman who posed for the painting was Marion Alice (Polly) Barnard, whose father, Frederick, was a painter and friend of Sargent's. Sargent scholar David McKibbin, who knew the Barnard sisters, specified that it was painted in 1912 at Abries, in the French Alps, a few kilometers from the Italian border.

National Atlas of West Nile Virus Activity
The National Atlas of the United States & CDC have combined to produce a set of interactive maps, with detail down to county level, to be updated weekly, showing WNV activity

West Nile Virus: Links to City and State Websites
Links to public health department information about WNV.

West Nile Virus Resources  
Contains a list of publications and guidelines from CDC for surveillance and control of WNV. It also includes information about animals and poultry from the Department of Agriculture and wildlife from the U.S. Geological Service.

Pesticides and Mosquito Control
Fact sheets from the Environmental Protection Agency about mosquito control and effective pesticides.

Information for Consumers
From the New York Department of Health. Has fact sheets on topics related to WNV and it's prevention and control and educational materials (many with links to additional information)

Questions and Answers about West Nile Virus
From the New York Department of Health. Facts for the public about the disease, how it is transmitted, and prevention methods.

West Nile Virus Fact Sheets
From the New York Department of Health. A list of fact sheets for the general public on a variety of topics such as eliminating mosquitoes, outdoor workers, various pesticides, personal precautions, and pets.

West Nile Virus Surveillance
From Health Canada. Information about WNV, including information sheets for the general public.

CLINICIAN

Epidemic/Epizootic West Nile Virus in the United States: Revised Guidelines for Surveillance, Prevention, and Control
To assess the implications of the WNV introduction into the U.S. and to develop a comprehensive national response plan, the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Agriculture (USDA) co-sponsored a meeting of arbovirologists, epidemiologists, laboratorians, vector-control specialists, wildlife biologists, and state and local health and agriculture officials in Fort Collins, Colorado, on November 8-9, 1999. As an outgrowth of this meeting, recommendations for surveillance, prevention and control of WNV in the U.S. were developed, published and used in 2000 by federal, state and local public health officials. A second national meeting, co-sponsored by CDC, the Association of Public Health Laboratories and other federal and state organizations was held in Charlotte, North Carolina, on January 31-February 4, 2001, to review year 2000 WNV activity, and evaluate the outcomes of recommended surveillance, prevention and control activities. Based on the results of this second meeting, modified Guidelines were formulated.

West Nile Virus A Reemerging Global Pathogen
The recognition of WNV in the Western Hemisphere in the summer of 1999 marked the first introduction in recent history of an Old World flavivirus into the New World. The United States is not alone, however, in reporting new or heightened activity in humans and other animals, and incursions of flaviviruses into new areas are likely to continue through increasing global commerce and travel. Similar expansion of other flaviviruses has been documented. Dengue viruses, perhaps the most important human flaviviral pathogens, have spread from roots in Asia to all tropical regions. Japanese encephalitis (JE) virus has recently encroached on the northern shores of Australia and may soon become endemic in that continent. This issue of Emerging Infectious Diseases focuses on current understanding of the biology, ecology, and epidemiology of WNV.

Crow Deaths as a Sentinel Surveillance System for West Nile Virus in the Northeastern United States, 1999
Abstract: In addition to human encephalitis and meningitis cases, the WNV outbreak in the summer and fall of 1999 in New York State resulted in bird deaths in New York, New Jersey, and Connecticut. From August to December 1999, 295 dead birds were laboratory-confirmed with WNV infection; 262 (89%) were American Crows (Corvus brachyrhynchos). The New York State Department of Health received reports of 17,339 dead birds, including 5,697 (33%) crows; in Connecticut 1,040 dead crows were reported. Bird deaths were critical in identifying WNV as the cause of the human outbreak and defining its geographic and temporal limits. If established before a WNV outbreak, a surveillance system based on bird deaths may provide a sensitive method of detecting WNV.

Serologic Evidence for West Nile Virus Infection in Birds in the New York City Vicinity during an Outbreak in 1999
Abstract: As part of an investigation of an encephalitis outbreak in New York City, we sampled 430 birds, representing 18 species in four orders, during September 13-23, 1999, in Queens and surrounding counties. Overall, 33% were positive for WNV-neutralizing antibodies, and 0.5% were positive for St. Louis encephalitis virus-neutralizing antibodies. By county, Queens had the most seropositive birds for WNV (50%); species with the greatest seropositivity for WNV (sample sizes were at least six) were Domestic Goose, Domestic Chicken, House Sparrow, Canada Goose, and Rock Dove. One sampled bird, a captive adult Domestic Goose, showed signs of illness; WNV infection was confirmed. Our results support the concept that chickens and House Sparrows are good arbovirus sentinels. This study also implicates the House Sparrow as an important vertebrate reservoir host.

West Nile Virus Isolates from Mosquitoes in New York and New Jersey, 1999
Abstract: An outbreak of encephalitis due to WNV occurred in New York City and the surrounding areas during 1999. Mosquitoes were collected as part of a comprehensive surveillance program implemented to monitor the outbreak. More than 32,000 mosquitoes representing 24 species were tested, and 15 WNV isolates were obtained. Molecular techniques were used to identify the species represented in the WNV-positive mosquito pools. Most isolates were from pools containing Culex pipiens mosquitoes, but several pools contained two or more Culex species.

Dead Bird Surveillance as an Early Warning System for West Nile Virus
Abstract: As part of WNV surveillance in New York State in 2000, 71,332 ill or dead birds were reported; 17,571 (24.6%) of these were American Crows. Of 3,976 dead birds tested, 1,263 (31.8%) were positive for WNV. Viral activity was first confirmed in 60 of the state's 62 counties with WNV-positive dead birds. Pathologic findings compatible with WNV were seen in 1,576 birds (39.6% of those tested), of which 832 (52.8%) were positive for WNV. Dead crow reports preceded confirmation of viral activity by several months, and WNV-positive birds were found >3 months before the onset of human cases. Dead bird surveillance appears to be valuable for early detection of WNV and for guiding public education and mosquito control efforts.

West Nile Virus Surveillance in Connecticut in 2000 An Intense Epizootic without High Risk for Severe Human Disease
Abstract: In 1999, Connecticut was one of three states in which WNV actively circulated prior to its recognition. In 2000, prospective surveillance was established, including monitoring bird deaths, testing dead crows, trapping and testing mosquitoes, testing horses and hospitalized humans with neurologic illness, and conducting a human seroprevalence survey. WNV was first detected in a dead crow found on July 5 in Fairfield County. Ultimately, 1,095 dead crows, 14 mosquito pools, 7 horses, and one mildly symptomatic person were documented with WNV infection. None of 86 hospitalized persons with neurologic illness (meningitis, encephalitis, Guillain-Barré-like syndrome) and no person in the seroprevalence survey were infected. Spraying in response to positive surveillance findings was minimal. An intense epizootic of WNV can occur without having an outbreak of severe human disease in the absence of emergency adult mosquito management.

Mosquito Surveillance and Polymerase Chain Reaction Detection of West Nile Virus, New York State
Abstract: WNV was detected in the metropolitan New York City (NYC) area during the summer and fall of 1999. Sixty-two human cases, 7 fatal, were documented. The New York State Department of Health initiated a departmental effort to implement a statewide mosquito and virus surveillance system. During the 2000 arbovirus surveillance season, we collected 317,676 mosquitoes, submitted 9,952 pools for virus testing, and detected 363 WNV-positive pools by polymerase chain reaction (PCR). Eight species of mosquitoes were found infected. Our mosquito surveillance system complemented other surveillance systems in the state to identify relative risk for human exposure to WNV. PCR WNV-positive mosquitoes were detected in NYC and six counties in the lower Hudson River Valley and metropolitan NYC area. Collective surveillance activities suggest that WNV can disperse throughout the state and may impact local health jurisdictions in the state in future years.

Partial Genetic Characterization of West Nile Virus Strains, New York State, 2000
Abstract: We analyzed nucleotide sequences from the envelope gene of 11 WNV strains collected in New York State during the 2000 transmission season to determine whether they differed genetically from each other and from the initial strain isolated in 1999. The complete envelope genes of these strains were amplified by reverse transcription-polymerase chain reaction. The resulting sequences were aligned, the genetic distances were computed, and a phylogenetic tree was constructed. Ten (0.7%) of 1,503 positions in the envelope gene were polymorphic in one or more sequences. The genetic distances were 0.003 or less. WNV strains circulating in 2000 were homogeneous with respect to one another and to a strain isolated in 1999.

Clinical Findings of West Nile Virus Infection in Hospitalized Patients, New York and New Jersey, 2000
Abstract: Outbreaks of WNV occurred in the New York metropolitan area in 1999 and 2000. Nineteen patients diagnosed with WN infection were hospitalized in New York and New Jersey in 2000 and were included in this review. Eleven patients had encephalitis or meningoencephalitis, and eight had meningitis alone. Ages of patients ranged from 36 to 87 years (median 63 years). Fever and neurologic and gastrointestinal symptoms predominated. Severe muscle weakness on neurologic examination was found in three patients. Age was associated with disease severity. Hospitalized cases and deaths were lower in 2000 than in 1999, although the case-fatality rate was unchanged. Clinicians in the Northeast should maintain a high level of suspicion during the summer when evaluating older patients with febrile illnesses and neurologic symptoms, especially if associated with gastrointestinal complaints or muscle weakness.

West Nile Encephalitis in Israel, 1999 The New York Connection
Abstract: We describe two cases of WNV encephalitis in a married couple in Tel Aviv, Israel, in 1999. Reverse transcription-polymerase chain reaction performed on a brain specimen from the husband detected a WN viral strain nearly identical to avian strains recovered in Israel in 1998 (99.9% genomic sequence homology) and in New York in 1999 (99.8%). This result supports the hypothesis that the 1999 WNV epidemic in the United States originated from the introduction of a strain that had been circulating in Israel.

Dead Crow Densities and Human Cases of West Nile Virus, New York State, 2000
Abstract: In 2000, Staten Island, New York, reported 10 human WNV cases and high densities of dead crows. Surrounding counties with <2 human cases had moderate dead crow densities, and upstate counties with no human cases had low dead crow densities. Monitoring such densities may be helpful because this factor may be determined without the delays associated with specimen collection and testing.

Equine West Nile Encephalitis, United States
Abstract: After the 1999 outbreak of WNV encephalitis in New York horses, a case definition was developed that specified the clinical signs, coupled with laboratory test results, required to classify cases of WN encephalitis in equines as either probable or confirmed. In 2000, 60 horses from seven states met the criteria for a confirmed case. The cumulative experience from clinical observations and diagnostic testing during the 1999 and 2000 outbreaks of WN encephalitis in horses will contribute to further refinement of diagnostic criteria.

Mosquito Surveillance for West Nile Virus in Connecticut, 2000 Isolation from Culex pipiens, Cx. restuans, Cx. salinarius, and Culiseta melanura
Abstract: Fourteen isolations of WNV were obtained from four mosquito species (Culex pipiens [5], Cx. restuans [4], Cx. salinarius [2], and Culiseta melanura [3]) in statewide surveillance conducted from June through October 2000. Most isolates were obtained from mosquitoes collected in densely populated residential locales in Fairfield and New Haven counties, where the highest rates of dead crow sightings were reported and where WNV was detected in 1999. Minimum field infection rates per 1,000 mosquitoes ranged from 0.5 to 1.8 (county based) and from 1.3 to 76.9 (site specific). Cx. restuans appears to be important in initiating WNV transmission among birds in early summer; Cx. pipiens appears to play a greater role in amplifying virus later in the season. Cs. melanura could be important in the circulation of WNV among birds in sylvan environments; Cx. salinarius is a suspected vector of WNV to humans and horses.

Clinical Characteristics of the West Nile Fever Outbreak, Israel, 2000
Abstract: WNV is endemic in Israel. The last reported outbreak had occurred in 1981. From August to October 2000, a large-scale epidemic of WN fever occurred in Israel; 417 cases were confirmed, with 326 hospitalizations. The main clinical presentations were encephalitis (57.9%), febrile disease (24.4%), and meningitis (15.9%). Within the study group, 33 (14.1%) hospitalized patients died. Mortality was higher among patients >70 years (29.3%). On multivariate regressional analysis, independent predictors of death were age >70 years (odds ratio [OR] 7.7), change in level of consciousness (OR 9.0), and anemia (OR 2.7). In contrast to prior reports, WN fever appears to be a severe illness with high rate of central nervous system involvement and a particularly grim outcome in the elderly.

West Nile Virus Infection in Birds and Mosquitoes, New York State, 2000
Abstract: WNV was found throughout New York State in 2000, with the epicenter in New York City and surrounding counties. We tested 3,403 dead birds and 9,954 mosquito pools for WNV during the transmission season. Sixty-three avian species, representing 30 families and 14 orders, tested positive for WNV. The highest proportion of dead birds that tested positive for WNV was in American Crows in the epicenter (67% positive, n=907). Eight mosquito species, representing four genera, were positive for WNV. The minimum infection rate per 1,000 mosquitoes (MIR) was highest for Culex pipiens in the epicenter: 3.53 for the entire season and 7.49 for the peak week of August 13. Staten Island had the highest MIR (11.42 for Cx. pipiens), which was associated with the highest proportion of dead American Crows that tested positive for WNV (92%, n=48) and the highest number of human cases (n=10).

West Nile Fever Outbreak, Israel, 2000 Epidemiologic Aspects
Abstract: From August 1 to October 31, 2000, 417 cases of WNV fever were serologically confirmed throughout Israel; 326 (78%) were hospitalized patients. Cases were distributed throughout the country; the highest incidence was in central Israel, the most populated part. Men and women were equally affected, and their mean age was 54±23.8 years (range 6 months to 95 years). Incidence per 1,000 population increased from 0.01 in the 1st decade of life to 0.87 in the 9th decade. There were 35 deaths (case-fatality rate 8.4%), all in patients >50 years of age. Age-specific case-fatality rate increased with age. Central nervous system involvement occurred in 170 (73%) of 233 hospitalized patients. The countrywide spread, number of hospitalizations, severity of the disease, and high death rate contrast with previously reported outbreaks in Israel.

West Nile Outbreak in Horses in Southern France, 2000 The Return after 35 Years
Abstract: On September 6, 2000, two cases of equine encephalitis caused by WNV were reported in southern France (Hérault Province), near Camargue National Park, where a WN outbreak occurred in 1962. Through November 30, 76 cases were laboratory confirmed among 131 equines with neurologic disorders. The last confirmed case was on November 3, 2000. All but three cases were located in a region nicknamed "la petite Camargue," which has several large marshes, numerous colonies of migratory and resident birds, and large mosquito populations. No human case has been confirmed among clinically suspected patients, nor have abnormal deaths of birds been reported. A serosurvey has been undertaken in horses in the infected area, and other studies are in progress.

The Relationships between West Nile and Kunjin Viruses
Abstract: Until recently, WN and Kunjin (KUN) viruses were classified as distinct types in the Flavivirus genus. However, genetic and antigenic studies on isolates of these two viruses indicate that the relationship between them is more complex. To better define this relationship, we performed sequence analyses on 32 isolates of KUN virus and 28 isolates of WNV from different geographic areas, including a WN isolate from the recent outbreak in New York. Sequence comparisons showed that the KUN virus isolates from Australia were tightly grouped but that the WNV isolates exhibited substantial divergence and could be differentiated into four distinct groups. KUN virus isolates from Australia were antigenically homologous and distinct from the WN isolates and a Malaysian KUN virus. Our results suggest that KUN and WNVes comprise a group of closely related viruses that can be differentiated into subgroups on the basis of genetic and antigenic analyses.

Rapid Determination of HLA B07 Ligands from the West Nile Virus NY99 Genome
Abstract: Defined T cell epitopes for WNV may be useful for developing subunit vaccines against WNV infection and diagnostic reagents to detect WNV-specific immune response. We applied a bioinformatics (EpiMatrix) approach to search the WNV NY99 genome for HLA B*07 restricted cytotoxic T cell (CTL) epitopes. Ninety-five of 3,433 WNV peptides scored above a predetermined cutoff, suggesting that these would be likely to bind to HLA B*07 and would also be likely candidate CTL epitopes. Compared with other methods for genome mapping, derivation of these ligands was rapid and inexpensive. Major histocompatibility complex ligands identified by this method may be used to screen T cells from WNV-exposed persons for cell-mediated response to WNV or to develop diagnostic reagents for immunopathogenesis studies and epidemiologic surveillance.

West Nile Virus Infection in the Golden Hamster (Mesocricetus auratus) A Model for West Nile Encephalitis
Abstract: This report describes a new hamster model for WNV encephalitis. Following intraperitoneal inoculation of a New York isolate of WNV, hamsters had moderate viremia of 5 to 6 days in duration, followed by the development of humoral antibodies. Encephalitic symptoms began 6 days after infection; about half the animals died between the seventh and 14th days. The appearance of viral antigen in the brain and neuronal degeneration also began on the sixth day. WNV was cultured from the brains of convalescent hamsters up to 53 days after initial infection, suggesting that persistent virus infection occurs. Hamsters offer an inexpensive model for studying the pathogenesis and treatment of WNV encephalitis.

West Nile Virus Infection In Mosquitoes, Birds, Horses and Humans, Staten Island, New York, 2000
Abstract: WNV transmission in the United States during 2000 was most intense on Staten Island, New York, where 10 neurologic illnesses among humans and 2 among horses occurred. WNV was isolated from Aedes vexans, Culex pipiens, Cx. salinarius, Ochlerotatus triseriatus, and Psorophora ferox, and WN viral RNA was detected in Anopheles punctipennis. An elevated weekly minimum infection rate (MIR) for Cx. pipiens and increased dead bird density were present for 2 weeks before the first human illness occurred. Increasing mosquito MIRs and dead bird densities in an area may be indicators of an increasing risk for human infections. A transmission model is proposed involving Cx. pipiens and Cx. restuans as the primary enzootic and epizootic vectors among birds, Cx. salinarius as the primary bridge vector for humans, and Aedes/Ochlerotatus spp. as bridge vectors for equine infection.

Experimental Infection of Chickens as Candidate Sentinels for West Nile Virus
Abstract: We evaluated the susceptibility, duration and intensity of viremia, and serologic responses of chickens to WNV (WNV-NY99) infection by needle, mosquito, or oral inoculation. None of 21 infected chickens developed clinical disease, and all these developed neutralizing antibodies. Although viremias were detectable in all but one chicken, the magnitude (mean peak viremia <104 PFU/mL) was deemed insufficient to infect vector mosquitoes. WNV-NY99 was detected in cloacal and/or throat swabs from 13 of these chickens, and direct transmission of WNV-NY99 between chickens occurred once (in 16 trials), from a needle-inoculated bird. Nine chickens that ingested WNV-NY99 failed to become infected. The domestic chickens in this study were susceptible to WNV infection, developed detectable antibodies, survived infection, and with one exception failed to infect cage mates. These are all considered positive attributes of a sentinel species for WNV surveillance programs.

Widespread West Nile Virus Activity, Eastern United States, 2000
Abstract: In 1999, the U.S. WNV epidemic was preceded by widespread reports of avian deaths. In 2000, ArboNET, a cooperative WNV surveillance system, was implemented to monitor the sentinel epizootic that precedes human infection. This report summarizes 2000 surveillance data, documents widespread virus activity in 2000, and demonstrates the utility of monitoring virus activity in animals to identify human risk for infection.

Exposure of Domestic Mammals to West Nile Virus during an Outbreak of Human Encephalitis, New York City, 1999
Abstract: We evaluated WNV seroprevalence in healthy horses, dogs, and cats in New York City after an outbreak of human WNV encephalitis in 1999. Two (3%) of 73 horses, 10 (5%) of 189 dogs, and none of 12 cats tested positive for WNV- neutralizing antibodies. Domestic mammals should be evaluated as sentinels for local WNV activity and predictors of the infection in humans.

Detection of North American West Nile Virus in Animal Tissue by a Reverse Transcription-Nested Polymerase Chain Reaction Assay
Abstract: A traditional single-stage reverse transcription-polymerase chain reaction (RT-PCR) procedure is effective in determining WNV in avian tissue and infected cell cultures. However, the procedure lacks the sensitivity to detect WNV in equine tissue. We describe an RT-nested PCR (RT-nPCR) procedure that identifies the North American strain of WNV directly in equine and avian tissues.

West Nile Virus in Overwintering Culex Mosquitoes, New York City, 2000
Abstract: After the 1999 WNV encephalitis outbreak in New York, 2,300 overwintering adult mosquitoes were tested for WNV by cell culture and reverse transcriptase-polymerase chain reaction. WN viral RNA and live virus were found in pools of Culex mosquitoes. Persistence in overwintering Cx. pipiens may be important in the maintenance of WNV in the northeastern United States.

West Nile Virus Outbreak Among Horses in New York State, 1999 and 2000
Abstract: WNV was identified in the Western Hemisphere in 1999. Along with human encephalitis cases, 20 equine cases of WNV were detected in 1999 and 23 equine cases in 2000 in New York. During both years, the equine cases occurred after human cases in New York had been identified.

Isolation and Characterization of West Nile Virus from the Blood of Viremic Patients During the 2000 Outbreak in Israel
Abstract: We report the isolation of WNV from four patient serum samples submitted for diagnosis during an outbreak of WN fever in Israel in 2000. Sequencing and phylogenetic analysis revealed two lineages, one closely related to a 1999 New York isolate and the other to a 1999 Russian isolate.

Fatal Encephalitis and Myocarditis in Young Domestic Geese (Anser anser domesticus) Caused by West Nile Virus
Abstract: During 1999 and 2000, a disease outbreak of WNV occurred in humans, horses, and wild and zoological birds in the northeastern USA. In our experiments, WNV infection of young domestic geese (Anser anser domesticus) caused depression, weight loss, torticollis, opisthotonus, and death with accompanying encephalitis and myocarditis. Based on this experimental study and a field outbreak in Israel, WNV is a disease threat to young goslings and viremia levels are potentially sufficient to infect mosquitoes and transmit WNV to other animal species.

Comparative West Nile Virus Detection in Organs of Naturally Infected American Crows (Corvus brachyrhynchos)
Abstract: Widespread deaths of American Crows (Corvus brachyrhynchos) were associated with the 1999 outbreak of WNV in the New York City region. We compared six organs from 20 crow carcasses as targets for WNV detection. Half the carcasses had at least one positive test result for WNV infection. The brain was the most sensitive target organ; it was the only positive organ for three of the positive crows. The sensitivity of crow organs as targets for WNV detection makes crow death useful for WNV surveillance.

Identification of Arboviruses and Certain Rodent-Borne Viruses Reevaluation of the Paradigm (Commentary)
Diagnostic and epidemiologic virology laboratories have in large part traded conventional techniques of virus detection and identification for more rapid, novel, and sensitive molecular methods. By doing so, useful phenotypic characteristics are not being determined. We feel that the impact of this shift in emphasis has impaired studies of the biology of viruses. This position paper is a plea to the scientific and administrative communities to reconsider the importance of such information. We also suggest a revised paradigm for virus isolation and characterization and provide a rationale for accumulating biologic (phenotypic) information.

Treatment of West Nile Virus Encephalitis with Intravenous Immunoglobulin (Letter)
WNV is endemic in Israel. The overwhelming majority of infections are mild and asymptomatic, but there have been periodic symptomatic outbreaks. In August 2000, an epidemic of WNV broke out in Israel, with >260 confirmed cases and 20 deaths by the end of September 2000. Hitherto, the only treatment for this condition has been supportive with no proven in vivo specific therapy, although ribavirin has shown promise in in vitro studies. We report an apparent dramatic response to intravenous immunoglobulin in an immunosuppressed patient and suggest that this was the result of specific antibodies in the Israeli immunoglobulin used.

 

 

 


 

APIC does not endorse or recommend the products or services of any commercial entity.
Association for Professionals in Infection Control and Epidemiology, Inc. 
1275 K St., NW, Suite 1000, Washington, DC, 20005-4006 (p) 202.789.1890 (f) 202.789.1899
apicinfo@apic.org |  Privacy Policy   |  Terms of Use